Zepbound/Tirzepatide

Zepbound/Tirzepatide – is a prescribed once a week injection that contains tirzepatide for the treatment of type 2 diabetes and reducing cardiovascular risk. It falls into the category of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. This dual mechanism aims to enhance blood sugar management and aid in weight control for those with type 2 diabetes. It is crucial to seek advice from a healthcare professional for personalized recommendations on the usage of tirzepatide for managing diabetes, weight loss, or any other health concerns.